中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

左半肝切除术治疗Schnelldorfer C型多囊肝1例报告

曾齐 沙地克·阿帕尔 吴警 努尔扎提江·安维尔 李涛 吐尔洪江·吐逊

引用本文:
Citation:

左半肝切除术治疗Schnelldorfer C型多囊肝1例报告

DOI: 10.3969/j.issn.1001-5256.2020.08.032
基金项目: 

新疆维吾尔自治区科技厅重点实验室开放课题项目(2018D04002); 新疆维吾尔自治区天山青年计划博士科技人才培养项目(2017Q094); 

详细信息
  • 中图分类号: R657.3

Left hemihepatectomy for Schnelldorfer type C polycystic liver disease: A case report

Research funding: 

 

  • 摘要:

    <正>多囊肝(polycystic liver disease,PLD)是一类罕见的基因病,既可作为常染色体显性PLD单独存在,也可伴随常显或常隐多囊肾[1]。PLD的主要特点是胆管上皮细胞的过度生长,表现为肝实质多个弥散分布的囊性病变,常与成人多囊肾伴发。该病早期常无典型的症状及体征,肝功能正常,但中晚期随着肝体积的增大可出现腹胀、腹痛及腹部包块,影响患者的正常生活[2]。目前的治疗方式主要分为内科药物治疗和外科手术

     

  • [1] BAE KT,ZHU F,CHAPMAN AB,et al. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease:The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort[J]. Clin J Am Soc Nephrol,2006,1(1):64-69.
    [2] WANG JR,YANG HY,MAO YL. Gene complexies,pathogenesis and clinical management of polycystic liver disease[J]. J Abdominal Surg,2019,32(6):459-464.(in Chinese)汪佳儒,杨华瑜,毛一雷.多囊肝病的相关基因、发病机制与临床治疗进展[J].腹部外科,2019,32(6):459-464.
    [3] D'AGNOLO HM,KIEVIT W,van MUNSTER KN,et al. Center is an important indicator for choice of invasive therapy in polycystic liver disease[J]. Transpl Int,2017,30(1):76-82.
    [4] D'AGNOLO HM,KIEVIT W,ANDRADE RJ,et al. Creating an effective clinical registry for rare diseases[J]. United European Gastroenterol J,2016,4(3):333-338.
    [5] GIGOT JF,JADOUL P,QUE F,et al. Adult polycystic liver disease:Is fenestration the most adequate operation for long-term management?[J]. Ann Surg,1997,225(3):286-294.
    [6] SCHNELLDORFER T,TORRES VE,ZAKARIA S,et al. Polycystic liver disease:A critical appraisal of hepatic resection,cyst fenestration,and liver transplantation[J]. Ann Surg,2009,250(1):112-118.
    [7] DAN AA,YOUNOSSI ZM. Quality of life and liver transplantation in patients with polycystic liver disease[J]. Liver Transpl,2006,12(8):1184-1185.
    [8] BERNTS L,DRENTH J,TJWA E. Management of portal hypertension and ascites in polycystic liver disease[J]. Liver Int,2019,39(11):2024-2033.
    [9] MACUTKIEWICZ C,PLASTOW R,CHRISPIJN M,et al. Complications arising in simple and polycystic liver cysts[J].World J Hepatol,2012,4(12):406-411.
    [10] XU XL,GAO CC,WANG ZX,et al. Advances in the diagnosis and treatment of cystic space-occupying lesions in the liver[J]. J Clin Hepatol,2019,35(5):1118-1122.(in Chinese)许晓磊,高灿灿,王志鑫,等.肝囊性占位性病变的诊断与治疗[J].临床肝胆病杂志,2019,35(5):1118-1122.
    [11] AUSSILHOU B,DOKMAK S,DONDERO F,et al. Treatment of polycystic liver disease. Update on the management[J]. J Visc Surg,2018,155(6):471-481.
    [12] van AERTS R,van de LAARSCHOT L,BANALES JM,et al.Clinical management of polycystic liver disease[J]. J Hepatol,2018,68(4):827-837.
    [13] DINDO D,DEMARTINES N,CLAVIEN PA. Classification of surgical complications:A new proposal with evaluation in a cohort of6336 patients and results of a survey[J]. Ann Surg,2004,240:205-213.
  • 加载中
计量
  • 文章访问数:  1224
  • HTML全文浏览量:  24
  • PDF下载量:  128
  • 被引次数: 0
出版历程
  • 出版日期:  2020-08-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回